CompletedN/Aketamine
Infusion Treatments of Chronic Peripheral Neuropathic Pain
Sponsored by Hacettepe University
NCT ID
NCT06297915
Target Enrollment
102 participants
Start Date
2022-05-17
Est. Completion
2023-08-01
About This Study
This study aimed to evaluate and compare the efficacy of ketamine and lidocaine infusion in patients with chronic peripheral neuropathic pain. Patients who received intravenous ketamine infusion and the other patient group who received intravenous lidocaine infusion were evaluated in the study. Pain scores and quality of life were assessed with scales before treatment at two weeks, two months, and six months after treatment.
Conditions Studied
Interventions
- •Ketamine
- •Lidocain
Eligibility
Age:18 Years - 65 Years
View full eligibility criteria
Inclusion Criteria: * 18-65 years of age * Patients with peripheral neuropathic pain (radicular neuropathy, diabetic neuropathy, complex regional pain syndrome type 2, traumatic peripheral nerve injury, trigeminal neuralgia, postherpetic neuralgia) * Patients who was evaluated by DN4 scores with of ≥4 points Exclusion Criteria: * Patients with central nervous system disease . * Patients with cancer related neuropatic pain. * Patients with central neuropathic pain patterns. * Patients with renal, hepatic, cardiovascular, and psychiatric diseases. * Patients whose treatment could not be completed due to side effects or other reasons. * Patients who had lost their follow-up .
Study Locations (1)
Hacettepe University
Ankara, Cankaya, Turkey (Türkiye)